Non contrast-enhanced short-time MRI and conventional CT: Comparison of diagnostic parameters in patients with acute neurological symptoms

Organizational Data

DRKS-ID:
DRKS00013356
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2017-12-01
Last update in DRKS:
2024-01-02
Registration type:
Prospective

Acronym/abbreviation of the study

Ultrafast Brain MRI in Acute Neurological Emergencies: the FAMILIES trial (LMU-RAD00055)

URL of the study

No Entry

Brief summary in lay language

This study begins with the selection of suitable patients in accordance to our specified inclusion and exclusion criteria which are based upon consultations with our colleagues in the interdisciplinary emergency department (neurology and neurosurgery). The patient’s cranial computed tomography (CT) images, taken as part of the standard emergency routine, will be evaluated a second time. Sufficient explanation of the patient’s symptoms by CT and study compatibility will be discussed with the treating physician. In the case of an insufficient CT result, the patient will be informed about the study, the use of encoded (pseudonymised) data and the examination using magnet resonance imaging (MRI). The patient’s participation is limited to the MRI examinations, which will include both an accelerated (GOBrain, Siemens Healthineers, Erlangen, Germany) and a standard protocol. The standard and accelerated protocols will be performed in random order. Following the examination, a specialist will assess the results and record them in the radiological information system (RIS) for the treating physicians. All pathologies/observations will be documented. The CT and accelerated MRI protocol will be compared to the standard MRI protocol (reference standard). The investigation will compile data comparing the sensitivity and specificity, as well as rating the examination quality (1 - nondiagnostic, 2 - poor image quality and substantial artifacts, 3 - satisfactory, 4 - good image quality and minor artifacts, 5 - excellent image quality without artifacts) and gray-white matter differentiation (0 – no visible gray-white matter differentiation, 1 - unclear but recognizable borders, 2 - clear differentiation).

Brief summary in scientific language

Acute pathologies of the central nervous system are one of the most common reasons for an admission to an emergency department. Besides past medical history and the physical examination, prompt imaging procedures of the head are important to detect possible intracranial pathologies. The computed tomography (CT) of the head is an essential part of neurological emergency diagnostics. CT offers time efficient examinations and is widely spread in hospitals around the world. It is well suited to display high contrast structures (e.g. bones, air). However, alterations in low contrast structures (e.g. central nervous system) can often only be observed when they are very distinct. Alterations include hemorrhage, ischemia, edema, infarction and increased intracranial pressure (ICP). Therefore, CT is suboptimal for detailed diagnostics and differential diagnosis. The head MRI has distinct advantages during neurological emergency diagnostics, because of its higher soft tissue contrast and therefore superior diagnostic accuracy. However, the use of the head MRI for neurological emergency situations is limited because the examination procedure requires too much time (> 20 min for a standard head MRI protocol). To be able to make fast and precise therapy decisions, it is very important to have a fast, high resolution head imaging program. This study will evaluate a new head MRI protocol (GOBrain, Siemens Healthineers, Erlangen, Germany) which will reduce the standard head MRI examination time from 20 min to 5 min. The reduced acquisition time with this protocol may enable the use of the head MRI for acute emergency diagnostics. The prerequisite is that the accelerated MRI protocol will have to demonstrate an equivalent or better diagnostic value compared to standard MRI protocols. The goal of this study is to demonstrate the practicability and diagnostic value of the accelerated head MRI protocol in comparison to standard head MRI protocols, as well as CT head protocols.

Health condition or problem studied

ICD10:
I67.88
ICD10:
I63.0 - Cerebral infarction due to thrombosis of precerebral arteries
ICD10:
R58 - Haemorrhage, not elsewhere classified
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
This study begins with the selection of suitable patients in accordance to our specified inclusion and exclusion criteria which are based upon consultations with our colleagues in the interdisciplinary emergency department (neurology and neurosurgery). The patient’s cranial computed tomography (CT) images, taken as part of the standard emergency routine, will be evaluated a second time. Sufficient explanation of the patient’s symptoms by CT and study compatibility will be discussed with the treating physician. In the case of an insufficient CT result, the patient will be informed about the study, the use of encoded (pseudonymised) data and the examination using magnet resonance imaging (MRI). The patient’s participation is limited to the MRI examinations, which will include both an accelerated (GOBrain, Siemens Healthineers, Erlangen, Germany) and a standard protocol. The standard and accelerated protocols will be performed in random order. Following the examination, a specialist will assess the results and record them in the radiological information system (RIS) for the treating physicians. All pathologies/observations will be documented. The CT and accelerated MRI protocol will be compared to the standard MRI protocol (reference standard). The investigation will compile data comparing the sensitivity and specificity, as well as rating the examination quality (1 - nondiagnostic, 2 - poor image quality and substantial artifacts, 3 - satisfactory, 4 - good image quality and minor artifacts, 5 - excellent image quality without artifacts) and gray-white matter differentiation (0 – no visible gray-white matter differentiation, 1 - unclear but recognizable borders, 2 - clear differentiation).

Endpoints

Primary outcome:
The primary outcome of this study will be accomplished after the examination results have been assessed by a specialist and the sensitivities and specificities of the CT examination, accelerated MRI protocol and standard MRI protocol have been determined. The sensitivities and specificities of the CT examination, accelerated MRI protocol and standard MRI protocol (reference standard) will be compared and evaluated. We assume that the results of the standard and accelerated protocols will be virtually identical and the accelerated protocol will prove to be superior to CT.
Secondary outcome:
Two blinded, independent readers will analyze all pseudonymised records. All pathologies/observations detected in the accelerated and standard MRI protocols will be recorded. Additionally, examination quality of the accelerated and standard MRI protocols will be assessed analogous to Prakkamukal et al. (J Neuroimaging 2016;26:503-510) (1 - nondiagnostic, 2 - poor image quality and substantial artifacts, 3 - satisfactory, 4 - good image quality and minor artifacts, 5 - excellent image quality without artifacts). Gray-white matter differentiation will also be assessed analogous to Prakkamukal et al. (0 – no visible gray-white matter differentiation, 1 - unclear but recognizable borders, 2 - clear differentiation).

Study Design

Purpose:
Diagnostic
Allocation:
N/A (single arm study)
Control:
  • Uncontrolled/single arm
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Single (group)
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Klinik und Poliklinik für Radiologie München

Recruitment period and number of participants

Planned study start date:
2017-12-01
Actual study start date:
2017-12-05
Planned study completion date:
No Entry
Actual Study Completion Date:
2019-01-30
Target Sample Size:
150
Final Sample Size:
150

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
- patients of the emergency department of the Ludwig-Maximilians-University (LMU) Munich-Großhadern (minimum age 18 years) - suspected intracranial pathologies (hemorrhage, ischemia, tumor, signs of inflammation, edema, increased intracranial pressure (ICP)) - insufficient explanation of symptoms after examination using the cranial computed tomography

Exclusion Criteria

- patients with MRI-incompatible intracorporeal material (e.g. pacemaker, bladder pacemaker, nerve stimulators) - lacking capability of giving consent - minors - claustrophobia - unstable general condition - pregnancy - sufficient explanation of symptoms by the cranial computed tomography

Addresses

Primary Sponsor

Address:
Klinikum der Universität München, Campus Großhadern
Marchioninistraße 15
81377 München
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.klinikum.uni-muenchen.de
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Klinikum der Universität München
Prof. Clemens Cyran
Marchioninistr. 15
81377 München
Germany
Telephone:
+49 89 4400-73620
Fax:
(089) 4400-76648
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.klinikum.uni-muenchen.de/de/index.html

Contact for Public Queries

Address:
Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern
Christel Besseler
Marchioninistr. 15
81377 München
Germany
Telephone:
(089) 4400-73652
Fax:
(089) 4400-76648
Contact per E-Mail:
Contact per E-Mail
URL:
http://intranet.klinikum.uni-muenchen.de/de/index.html

Principal Investigator

Address:
Klinikum der Universität München
Prof. Clemens Cyran
Marchioninistr. 15
81377 München
Germany
Telephone:
+49 89 4400-73620
Fax:
(089) 4400-76648
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.klinikum.uni-muenchen.de/de/index.html

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern
Marchioninistr. 15
81377 München
Germany
Telephone:
(089) 4400-4400 72750
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Med. Fakultät der LMU
Pettenkoferstraße 8
80336 München
Germany
Telephone:
+49-89-440055191
Fax:
+49-89-440055192
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2017-06-12
Ethics committee number:
17-435
Vote of the Ethics Committee:
Approved
Date of the vote:
2017-09-08

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
Other secondary IDs:
interne Studiennummer - LMU-RAD00055
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Publication of study results

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
Results: Ninety-three additional intracranial lesions (acute ischemia, n = 21; intracranial hemorrhage/microbleeds, n = 27; edema, n = 2; white matter lesion, n = 38; chronic infarction, n = 3; others, n = 2) were detected by ultrafast-MRI, whereas 101 additional intracranial lesions were detected by the standard-length protocol (acute ischemia, n = 24; intracranial hemorrhage/microbleeds, n = 32; edema, n = 2; white matter lesion, n = 38; chronic infarction, n = 3; others, n = 2). Image quality was equivalent to the standard-length protocol. Ultrafast-MRI demonstrated high diagnostic accuracy (sensitivity, 0.939 [0.881-0.972]; specificity, 1.000 [0.895-1.000]) for the detection of intracranial pathologies. MRI led to a change in patient management in 10% compared with the initial CT. Conclusions: Ultrafast-MRI enables time-optimized diagnostic workup in acute neurological emergencies at high sensitivity and specificity compared with a standard-length protocol, with direct impact on patient management. Ultrafast MRI protocols are a powerful tool in the emergency setting and may be implemented on various scanner types based on the optimization of individual acquisition parameters.